Oramed Pharmaceuticals Inc. (ORMP) 当前追踪市盈率 (P/E) 为 1.9. 追踪盈利收益率为 53.27%. 格雷厄姆数为 $9.20.
本页证实的标准:
SharesGrow 综合评分： 69/100 其中 4/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -8.3 | -0.28 | 3.48 | 142.00 | - |
| 2017 | -11.0 | 1.19 | 5.98 | 46.88 | - |
| 2018 | -5.8 | -0.65 | 2.37 | 30.08 | - |
| 2019 | -4.0 | 0.87 | 2.99 | 21.44 | - |
| 2020 | -6.2 | 0.20 | 2.18 | 26.44 | - |
| 2021 | -25.2 | -0.64 | 4.84 | 207.28 | - |
| 2022 | -12.4 | -0.51 | 3.09 | 173.56 | - |
| 2023 | 16.9 | -0.15 | 0.57 | 69.50 | - |
| 2024 | -5.2 | 0.01 | 0.68 | 0.00 | - |
| 2025 | 1.6 | 0.00 | 0.59 | 59.00 | 9.21% |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-0.87 | $641K | $-10.96M | -1710.5% |
| 2017 | $-0.79 | $2.46M | $-10.48M | -426.7% |
| 2018 | $-0.86 | $2.45M | $-12.73M | -519.7% |
| 2019 | $-0.82 | $2.7M | $-14.36M | -531.1% |
| 2020 | $-0.56 | $2.71M | $-11.51M | -424.8% |
| 2021 | $-0.78 | $2.7M | $-22.24M | -822.7% |
| 2022 | $-0.97 | $2.7M | $-37.76M | -1397.1% |
| 2023 | $0.14 | $1.34M | $5.53M | 412.3% |
| 2024 | $-0.47 | $0.00 | $-19.1M | - |
| 2025 | $1.50 | $2M | $75.32M | 3766.2% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-1.26 | $-1.26 – $-1.26 | $1.25M | $1.25M – $1.25M | 1 |
| 2027 | $-0.82 | $-0.82 – $-0.82 | $778.59K | $778.59K – $778.59K | 1 |
